Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer

Cancer Science

Volumn 99, Issue 7, 2008, Pages 1341-1347

  Kitajima, Yoshihiko ^a   Ide, Takao ^a   Ohtsuka, Takao ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE GROWTH FACTOR ACTIVATOR PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; LUCIFERASE; MESSENGER RNA; SCATTER FACTOR RECEPTOR; SERINE PROTEINASE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER INVASION; CELL ACTIVATION; CONTROLLED STUDY; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES;

EID: 44449113872     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00828.x     Document Type: Article

References (30)

1. Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3.
2. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-8.
3. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600.
4. Gak E, Taylor WG, Chan AML, Rubin JS. Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett 1992; 311: 17-21.
5. Miyazawa K, Shimomura T, Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 1996; 271: 3615-18.
6. Miyazawa K, Shimomura T, Daiji N, Kitamura N. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 1994; 269: 8966-70.
7. Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M. Activation of hepatocyte growth factor/scatter in colorectal carcinoma. Cancer Res 2000; 60: 6148-59.
8. Tjin EP, Derksen PW, Kataoka H, Spaargaren M, Pals ST. Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator. Blood 2004; 104: 2172-5.
9. Parr C, Watkins G, Mansel RE, Jiang WG. The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 2004; 10: 202-11.
10. Uchinokura S, Miyata S, Fukushima T et al. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo. Int J Cancer 2006; 118: 583-92.
11. Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: Role of hypoxia and anemia. Med Oncol 2001; 18: 243-59.
12. Rice GC, Hoy C, Schimke RT. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 1986; 83: 5978-82.
13. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509-15.
14. 2-regulated prolyl hydroxylation. Science 2001; 292: 468-72.
15. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev 2003; 3: 721-32.
16. Kaelin WG. How oxygen makes its presence felt. Genes Dev 2002; 16: 1441-5.
17. Semenza GL. Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology (Bethesda) 2004; 19: 176-82.
18. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-65.
19. Koong AC, Mehta VK, Le QT et al. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys 2000; 48: 919-22.
20. Shibaji T, Nagao M, Ikeda N et al. Prognostic significance of HIF-1α overexpression in human pancreatic cancer. Anticancer Res 2003; 23: 4721-8.
21. Ide T, Kitajima Y, Miyoshi A et al. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer through the hapatocyte growth factor/c-Met pathway. Int J Cancer 2006; 119: 2750-9.
22. Ide T, Kitajima Y, Miyoshi A et al. The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling. Ann Surg Oncol 2007; 14: 2600-7.
23. Miyoshi A, Kitajima Y, Sumi K et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. B J Cancer 2004; 90: 1265-73.
24. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993; 268: 10 024-8.
25. Shimomura T, Miyazawa K, Komiyama Y et al. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995; 229: 257-61.
26. Mukai T, Fukushima T, Naka D, Tanaka H, Osada Y, Kataoka H. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases. FEBS J 2008; 275: 1003-17.
27. Kang JY, Dolled-Filhart M, Ocal IT et al. Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res 2003; 63: 1101-5.
28. Oberst MD, Johnson MD, Dickson RB et al. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer. correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res 2002; 8: 1101-7.
29. Ihara S, Miyoshi E, Ko JH et al. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β1-6G1cNAc branching. J Biol Chem 2002; 277: 16960-7.
30. Hayashi M, Sakata M, Takeda T et al. Up-regulation of c-Met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension. Endocrinology 2005; 146: 4682-9.